Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023.
Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023. ·
Barrons.com
·
Photograph by Fabrice Coffrini/AFP/Getty Images
Mackenzie Tatananni
4 min read